Search company, investor...
Search

The profile is currenly unclaimed by the seller. All information is provided by CB Insights.

novabay.com

Founded Year

2000

Stage

Loan | IPO

Total Raised

$680K

Market Cap

0.01B

Stock Price

0.11

About NovaBay Pharmaceuticals

NovaBay Pharmaceuticals develops products for the eye care market. The company is focused on commercializing prescription Avenova for managing hygiene of the eyelids and lashes in the United States.

NovaBay Pharmaceuticals Headquarters Location

2000 Powell Street Suite 1150

Emeryville, California, 94608,

United States

510-899-8800

Predict your next investment

The CB Insights tech market intelligence platform analyzes millions of data points on venture capital, startups, patents , partnerships and news mentions to help you see tomorrow's opportunities, today.

Expert Collections containing NovaBay Pharmaceuticals

Expert Collections are analyst-curated lists that highlight the companies you need to know in the most important technology spaces.

NovaBay Pharmaceuticals is included in 1 Expert Collection, including Medical Devices.

M

Medical Devices

3,088 items

Companies that have been granted at least 1 510(k) by the FDA since 2014. Companies tagged as #FDA510(K)

NovaBay Pharmaceuticals Patents

NovaBay Pharmaceuticals has filed 10 patents.

patents chart

Application Date

Grant Date

Title

Related Topics

Status

10/31/2014

4/18/2017

Contact lenses, Epidermal nevi, neoplasms, cysts, Disorders of sclera and cornea, Microbiology, Corrective lenses

Grant

Application Date

10/31/2014

Grant Date

4/18/2017

Title

Related Topics

Contact lenses, Epidermal nevi, neoplasms, cysts, Disorders of sclera and cornea, Microbiology, Corrective lenses

Status

Grant

Latest NovaBay Pharmaceuticals News

NovaBay Pharmaceuticals to Present at the Ladenburg Thalmann 2022 Healthcare Conference

Sep 23, 2022

09/23/2022 | 06:51am EDT Message :   NovaBay® Pharmaceuticals, Inc. (NYSE American: NBY), a pharmaceutical company developing and commercializing high-quality, scientifically formulated eyecare and skincare products, announces that management will present at the Ladenburg Thalmann 2022 Healthcare Conference on Thursday, September 29 at 9:00 a.m. Eastern time (6:00 a.m. Pacific time). The conference is being held at the Sofitel Hotel New York. A webcast of the presentation will be available on the Events page of the company website. About NovaBay Pharmaceuticals, Inc: NovaBay Pharmaceuticals, Inc. is a pharmaceutical company that develops and sells scientifically created and clinically proven consumer products for the eyecare and skincare markets. Avenova® is the most prescribed antimicrobial lid and lash spray and DERMAdoctor® is a premium skincare brand offering more than 30 dermatologist-developed skincare products sold through traditional domestic retailers, digital beauty channels and international distributors. Socialize and Stay Informed on NovaBay’s Progress Like us on Facebook

NovaBay Pharmaceuticals Web Traffic

Rank
Page Views per User (PVPU)
Page Views per Million (PVPM)
Reach per Million (RPM)
CBI Logo

NovaBay Pharmaceuticals Rank

  • When was NovaBay Pharmaceuticals founded?

    NovaBay Pharmaceuticals was founded in 2000.

  • Where is NovaBay Pharmaceuticals's headquarters?

    NovaBay Pharmaceuticals's headquarters is located at 2000 Powell Street, Emeryville.

  • What is NovaBay Pharmaceuticals's latest funding round?

    NovaBay Pharmaceuticals's latest funding round is Loan.

  • How much did NovaBay Pharmaceuticals raise?

    NovaBay Pharmaceuticals raised a total of $680K.

  • Who are the investors of NovaBay Pharmaceuticals?

    Investors of NovaBay Pharmaceuticals include Paycheck Protection Program and Triton.

Discover the right solution for your team

The CB Insights tech market intelligence platform analyzes millions of data points on vendors, products, partnerships, and patents to help your team find their next technology solution.

Request a demo

CBI websites generally use certain cookies to enable better interactions with our sites and services. Use of these cookies, which may be stored on your device, permits us to improve and customize your experience. You can read more about your cookie choices at our privacy policy here. By continuing to use this site you are consenting to these choices.